Salts of Clopidogrel: Investigation to ENsure Clinical Equivalence "SCIENCE"


Phase N/A Results N/A

Eligibility Criteria

Inclusion Criteria

- Both sexes
- age >18 years
- age <85 years
- Patients with an ACS with or without percutaneous coronary intervention, stable CAD, history of an ischemic stroke/TIA, PAD, carotid artery disease or atrial fibrillation
- agree on study participation
- will comply with all required study procedures

Exclusion Criteria

- >85 years
- <18 years
Patients with
- hypersensitivity reaction or contraindication to clopidogrel,
- active bleeding or history of severe bleeding (peptic ulcer, trauma or intracranial hemorrhage),
- blood coagulation disorders,
- uncontrolled severe hypertension,
- history of drug or alcohol abuse,
- pregnancy or breastfeeding,
- liver disease
- chronic kidney disease,
- malignancy,
- disagree on study participation,
- evidence for poor compliance with all required study procedures